Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

Early identification of patients at high risk of group A streptococcus-associated necrotizing skin and soft tissue infections: a retrospective cohort study.

Urbina T, Hua C, Woerther PL, Mekontso Dessap A, Chosidow O, de Prost N.

Crit Care. 2019 Dec 21;23(1):417. doi: 10.1186/s13054-019-2708-y. No abstract available.

2.

How to eliminate scabies parasites from fomites - a high throughput ex vivo experimental study.

Bernigaud C, Fernando DD, Lu H, Taylor S, Hartel G, Chosidow O, Fischer K.

J Am Acad Dermatol. 2019 Dec 16. pii: S0190-9622(19)33301-8. doi: 10.1016/j.jaad.2019.11.069. [Epub ahead of print] No abstract available.

PMID:
31857110
3.

Cutaneous tests and interest of iobitridol in non-immediate hypersensitivity to contrast media: a case series of 43 patients.

Gaudin O, Deschamps O, Duong TA, Gener G, Paul M, Luciani A, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Assier H.

J Eur Acad Dermatol Venereol. 2019 Dec 9. doi: 10.1111/jdv.16139. [Epub ahead of print] No abstract available.

PMID:
31814161
4.

[Authors response to the letter on the article: "The place of Androcur® in the treatment of diffuse female pattern hair loss"].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Dec;146(12):822-823. doi: 10.1016/j.annder.2019.10.016. Epub 2019 Nov 12. French. No abstract available.

PMID:
31732137
5.

Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study.

Urbina T, Hua C, Sbidian E, Bosc R, Tomberli F, Lepeule R, Decousser JW, Mekontso Dessap A, Chosidow O, de Prost N; Henri Mondor Hospital Necrotizing Fasciitis group.

Ann Intensive Care. 2019 Oct 24;9(1):123. doi: 10.1186/s13613-019-0598-4.

6.

Pathogen identification by shotgun metagenomics of patients with necrotizing soft-tissue infections.

Rodriguez C, Jary A, Hua C, Woerther PL, Bosc R, Desroches M, Sitterlé E, Gricourt G, De Prost N, Pawlotsky JM, Chosidow O, Sbidian E, Decousser JW; Multidisciplinary Necrotizing Fasciitis Study Group.

Br J Dermatol. 2019 Oct 14. doi: 10.1111/bjd.18611. [Epub ahead of print]

PMID:
31610037
7.

Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions.

Bérot V, Gener G, Ingen-Housz-Oro S, Gaudin O, Paul M, Chosidow O, Wolkenstein P, Assier H.

J Eur Acad Dermatol Venereol. 2019 Sep 30. doi: 10.1111/jdv.15986. [Epub ahead of print]

PMID:
31571276
8.

In vitro ovicidal activity of current and under-development scabicides: which treatments kill scabies eggs?

Bernigaud C, Fernando DD, Lu H, Taylor S, Hartel G, Guillot J, Chosidow O, Fischer K.

Br J Dermatol. 2019 Sep 11. doi: 10.1111/bjd.18517. [Epub ahead of print] No abstract available.

PMID:
31508811
9.

Characteristics, Associated Diseases, and Management of Gram-negative Toe-web Infection: A French Experience.

Goiset A, Milpied B, Marti A, Marie J, Leroy-Colavolpe V, Pham-Ledard A, Chosidow O, Beylot-Barry M.

Acta Derm Venereol. 2019 Nov 1;99(12):1121-1126. doi: 10.2340/00015555-3315.

10.

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.

Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F.

BMJ Open. 2019 Aug 21;9(8):e027431. doi: 10.1136/bmjopen-2018-027431.

11.

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.

Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C; PsoBioTeq Study Group.

J Eur Acad Dermatol Venereol. 2019 Aug 16. doi: 10.1111/jdv.15878. [Epub ahead of print]

PMID:
31419355
12.

Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate.

Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, Gonzalez-Chiappe S, Wolkenstein P, Chosidow O, Mahr A, Fardet L.

Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18424. [Epub ahead of print]

PMID:
31396952
13.

Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial.

Leducq S, Samimi M, Bernier C, Soria A, Amsler E, Staumont-Sallé D, Gabison G, Chosidow O, Bénéton N, Bara C, Grange-Prunier A, Wierzbicka-Hainaut E, Brenaut E, Droitcourt C, Raison-Peyron N, Bourgoin H, Cornillier H, Machet L, Giraudeau B, Caille A, Maruani A.

J Am Acad Dermatol. 2020 Jan;82(1):240-243. doi: 10.1016/j.jaad.2019.07.097. Epub 2019 Aug 5. No abstract available.

PMID:
31394130
14.

Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients.

Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N.

Br J Dermatol. 2019 Aug 5. doi: 10.1111/bjd.18387. [Epub ahead of print]

PMID:
31385287
15.

Beard dermatitis induced by coloration.

Assier H, Wolkenstein P, Chosidow O.

Contact Dermatitis. 2019 Dec;81(6):471-473. doi: 10.1111/cod.13372. Epub 2019 Aug 21. No abstract available.

PMID:
31373026
16.

Are swabs an appropriate way to sample for skin microbiome research?

Bernigaud C, Chosidow O.

Br J Dermatol. 2019 Sep;181(3):444-445. doi: 10.1111/bjd.18257. Epub 2019 Jul 28. No abstract available.

PMID:
31353448
17.

Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017.

Bettuzzi T, Penso L, de Prost N, Hemery F, Hua C, Colin A, Mekontso-Dessap A, Fardet L, Chosidow O, Wolkenstein P, Sbidian E, Ingen-Housz-Oro S.

Br J Dermatol. 2020 Jan;182(1):247-248. doi: 10.1111/bjd.18360. Epub 2019 Sep 11. No abstract available.

PMID:
31323695
18.

Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option.

Hotz C, Sbidian E, Ingen-Housz-Oro S, Chosidow O, Wolkenstein P.

Acta Derm Venereol. 2019 Nov 1;99(12):1170-1171. doi: 10.2340/00015555-3268. No abstract available.

19.

Part I - Ectoparasites: Scabies.

Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY.

J Am Acad Dermatol. 2019 Jul 13. pii: S0190-9622(19)32385-0. doi: 10.1016/j.jaad.2019.05.109. [Epub ahead of print] Review.

PMID:
31310840
20.

Part II - Ectoparasites: Pediculosis and Tungiasis.

Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32386-2. doi: 10.1016/j.jaad.2019.05.110. [Epub ahead of print] Review.

PMID:
31306729
21.

Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016.

Traikia C, Hua C, Le Cleach L, de Prost N, Hemery F, Bettuzzi T, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Sbidian E.

Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18294. [Epub ahead of print]

PMID:
31260078
22.

Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns.

Lalevée S, Audureau E, Riou A, Colin A, Anquetin M, Barau C, Valeyrie-Allanore L, Delfau-Larue MH, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Hüe S.

Clin Exp Allergy. 2019 Sep;49(9):1258-1261. doi: 10.1111/cea.13449. Epub 2019 Jul 7. No abstract available.

PMID:
31206897
23.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
24.

Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation.

Deschamps O, Ortonne N, Hüe S, Rodriguez C, Deschodt C, Hirsch G, Colin A, Grégoire L, Delfau-Larue MH, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.

Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18166. [Epub ahead of print]

PMID:
31127953
25.

Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae.

Hajj C, Ezzedine K, Thorel D, Delcampe A, Royer G, Hua C, Colin A, de Prost N, Muraine M, Chosidow O, Wolkenstein P, Gueudry J, Ingen-Housz-Oro S.

Br J Dermatol. 2019 Aug;181(2):421-422. doi: 10.1111/bjd.18023. Epub 2019 Jun 6. No abstract available.

PMID:
31016732
26.

Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings.

Chosidow O, Hay RJ.

Lancet Infect Dis. 2019 May;19(5):454-456. doi: 10.1016/S1473-3099(19)30068-4. Epub 2019 Apr 4. No abstract available.

27.

[The place of Androcur® in the treatment of diffuse female pattern hair loss].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Apr;146(4):311-312. doi: 10.1016/j.annder.2019.02.008. Epub 2019 Mar 27. French. No abstract available.

PMID:
30926139
28.

Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases.

Lecadet A, Woerther PL, Hua C, Colin A, Gomart C, Decousser JW, Mekontso Dessap A, Wolkenstein P, Chosidow O, de Prost N, Ingen-Housz-Oro S.

J Am Acad Dermatol. 2019 Aug;81(2):342-347. doi: 10.1016/j.jaad.2019.03.030. Epub 2019 Mar 16.

PMID:
30890340
29.

Lookalike and soundalike drugs: a potential cause of cutaneous adverse reactions to drugs.

Cassius C, Davis CJ, Bravard P, Carre-Gislard D, Modiano P, Lebrun-Vignes B, Ingen-Housz-Oro S, Chosidow O.

Br J Dermatol. 2019 Sep;181(3):626-627. doi: 10.1111/bjd.17842. Epub 2019 Jun 18. No abstract available.

PMID:
30828784
30.

Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.

Halioua B, Paul C, Berbis P, Cambazard F, Doutre MS, Joly P, Richard MA, Aubin C, Gruber A, Chosidow O.

Eur J Dermatol. 2019 Feb 1;29(1):59-66. doi: 10.1684/ejd.2018.3484.

PMID:
30827949
31.

Cervical cutaneous sclerosis: the stomach is not far from the skin.

Gauci ML, Hua C, Ortonne N, Boussion H, Zehou O, Wolkenstein P, Chosidow O.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e177-e179. doi: 10.1111/jdv.15432. Epub 2019 Feb 18. No abstract available.

PMID:
30653760
32.

Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, Wolkenstein P, Royer G, Ezzedine K, Muraine M, Gueudry J.

Br J Dermatol. 2019 Jul;181(1):212-213. doi: 10.1111/bjd.17627. Epub 2019 Apr 29. No abstract available.

PMID:
30633324
33.

Severe contact allergy to mupirocin in a polysensitized patient.

Assier H, Hirsch G, Wolkenstein P, Chosidow O.

Contact Dermatitis. 2019 Jun;80(6):397-398. doi: 10.1111/cod.13208. Epub 2019 Feb 22. No abstract available.

PMID:
30624771
34.

Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects.

Poizeau F, Sbidian E, Mircher C, Rebillat AS, Chosidow O, Wolkenstein P, Ravel A, Hotz C.

Acta Derm Venereol. 2019 Mar 1;99(3):351-352. doi: 10.2340/00015555-3095. No abstract available.

35.

Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series.

Gendreau S, Amiot A, Le Baleur Y, Charpy C, Wolkenstein P, Chosidow O, Mekontso Dessap A, Ingen-Housz-Oro S, de Prost N.

Br J Dermatol. 2019 May;180(5):1234-1235. doi: 10.1111/bjd.17428. Epub 2019 Feb 13. No abstract available.

PMID:
30430542
36.

Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics.

Chaby G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Am Acad Dermatol. 2019 May;80(5):1453-1455. doi: 10.1016/j.jaad.2018.10.058. Epub 2018 Nov 2. No abstract available.

PMID:
30395917
37.

Non-Histaminergic Itch Mediators Elevated in the Skin of a Porcine Model of Scabies and of Human Scabies Patients.

Sanders KM, Nattkemper LA, Rosen JD, Andersen HH, Hsiang J, Romanelli P, Bernigaud C, Guillot J, Chosidow O, Yosipovitch G.

J Invest Dermatol. 2019 Apr;139(4):971-973. doi: 10.1016/j.jid.2018.09.032. Epub 2018 Nov 2. No abstract available.

PMID:
30395848
38.

[Diagnostic and therapeutic recommendations for sexually transmitted diseases: Genital herpes].

Milpied B, Janier M, Timsit J, Spenatto N, Caumes E, Chosidow O, Sentilhes L, Senat MV; Groupe infectiologie dermatologique et infections sexuellement transmissibles (GrIDIST) de la Société française de dermatologie et du Collège national des gynécologues obstétriciens français (CNGOF).

Ann Dermatol Venereol. 2019 Jan;146(1):31-36. doi: 10.1016/j.annder.2018.07.029. Epub 2018 Oct 23. Review. French.

PMID:
30366717
39.

Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.

Lalevee S, Ortonne N, Hotz C, Schlemmer F, Beldi-Ferchiou A, Delfau-Larue MH, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

Eur J Dermatol. 2018 Dec 1;28(6):834-835. doi: 10.1684/ejd.2018.3410. No abstract available.

PMID:
30325315
40.

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance.

Chaby G, Lebrun-Vignes B, Haddad C, Hemery F, Ingen-Housz-Oro S, de Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1344-1346. doi: 10.1016/j.jaip.2018.09.028. Epub 2018 Oct 5. No abstract available.

PMID:
30292922
41.

Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients.

Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong TA, Colin A, Bellivier F, Romano H, de Prost N, Chazelas K, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.

Br J Dermatol. 2019 May;180(5):1206-1213. doi: 10.1111/bjd.17267. Epub 2018 Dec 3.

PMID:
30282109
42.

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis.

Larsabal M, Ly S, Sbidian E, Moyal-Barracco M, Dauendorffer JN, Dupin N, Richard MA, Chosidow O, Beylot-Barry M.

Br J Dermatol. 2019 Mar;180(3):647-656. doi: 10.1111/bjd.17147. Epub 2018 Nov 1.

PMID:
30188572
43.

Effect of Diet in Chronic Spontaneous Urticaria: A Systematic Review.

Cornillier H, Giraudeau B, Samimi M, Munck S, Hacard F, Jonville-Bera AP, Jegou MH, d'Acremont G, Pham BN, Chosidow O, Maruani A.

Acta Derm Venereol. 2019 Feb 1;99(2):127-132. doi: 10.2340/00015555-3015.

44.

Association Between Severe Acute Contact Dermatitis Due to Nigella sativa Oil and Epidermal Apoptosis.

Gaudin O, Toukal F, Hua C, Ortonne N, Assier H, Jannic A, Giménez-Arnau E, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

JAMA Dermatol. 2018 Sep 1;154(9):1062-1065. doi: 10.1001/jamadermatol.2018.2120.

45.

Association Between Mediterranean Anti-inflammatory Dietary Profile and Severity of Psoriasis: Results From the NutriNet-Santé Cohort.

Phan C, Touvier M, Kesse-Guyot E, Adjibade M, Hercberg S, Wolkenstein P, Chosidow O, Ezzedine K, Sbidian E.

JAMA Dermatol. 2018 Sep 1;154(9):1017-1024. doi: 10.1001/jamadermatol.2018.2127.

46.

High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug.

Chosidow O, Bernigaud C, Do-Pham G.

Parasite. 2018;25:33. doi: 10.1051/parasite/2018039. Epub 2018 Jul 16.

47.

A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices.

Kechichian E, Ingen-Housz-Oro S, Sbidian E, Hemery F, Bernier C, Fite C, Delaunay J, Staumont-Sallé D, Toukal F, Dupin N, Abasq C, Samimi M, Picard C, Hebert V, Prost C, Monfort JB, Milpied B, Wolkenstein P, Chosidow O.

Br J Dermatol. 2018 Oct;179(4):1009-1011. doi: 10.1111/bjd.16928. Epub 2018 Aug 16. No abstract available.

PMID:
29957881
48.

Scabies Itch.

Jannic A, Bernigaud C, Brenaut E, Chosidow O.

Dermatol Clin. 2018 Jul;36(3):301-308. doi: 10.1016/j.det.2018.02.009. Epub 2018 May 1. Review.

PMID:
29929601
49.

Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation.

Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Mullins AJ, Tecle B, Kelly A, Sutra JF, Moreau F, Lilin T, Beugnet F, Botterel F, Chosidow O, Guillot J.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e02334-17. doi: 10.1128/AAC.02334-17. Print 2018 Sep.

50.

[Pemphigus and herpes: Multicentre survey and literature review].

Merlant M, Seta V, Bernard P, Fourati S, Meritet JF, Wolkenstein P, Dupin N, Joly P, Chosidow O, Ingen-Housz-Oro S.

Ann Dermatol Venereol. 2018 Aug - Sep;145(8-9):477-485. doi: 10.1016/j.annder.2018.03.169. Epub 2018 Jun 14. Review. French.

PMID:
29866471

Supplemental Content

Loading ...
Support Center